Acadian Asset Management
FBRX icon

Acadian Asset Management’s Forte Biosciences FBRX Stock Holding History

Acadian Asset Management’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-47
Closed -$17K – 2229
2020
Q2 		$17K Sell
47
-36
-43% -$16.1K ﹤0.01% 2143
2020
Q1 		$38K Sell
83
-490
-86% -$191K ﹤0.01% 1561
2019
Q4 		$114K Sell
573
-64
-10% -$14.5K ﹤0.01% 1418
2019
Q3 		$157K Buy
637
+390
+158% +$592K ﹤0.01% 1380
2019
Q2 		$618K Buy
247
+149
+152% +$442K ﹤0.01% 946
2019
Q1 		$401K Buy
98
+96
+4,800% +$371K ﹤0.01% 1158
2018
Q4 		$5K Buy
+2
New +$8.61K ﹤0.01% 1663

Other funds holding FBRX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return

Acadian Asset Management's FBRX Position: Q3 2020 in Review

Acadian Asset Management sold out of Forte Biosciences (FBRX) in Q3 2020, closing a stake of 47 shares — an estimated $17K sold.

Acadian Asset Management first reported a position in FBRX in Q4 2018 and held it in 7 quarters. The position peaked at $618K in Q2 2019. 47 funds tracked by Wall St. Rank hold FBRX as of Q3 2020.

  • Acadian Asset Management reported no remaining Forte Biosciences position as of Q3 2020 after selling out during the quarter.
  • Acadian Asset Management sold 47 Forte Biosciences shares in Q3 2020, an estimated $17K.
  • Acadian Asset Management first reported a position in Forte Biosciences in Q4 2018 and held it in 7 quarters.
  • Acadian Asset Management's Forte Biosciences position peaked at $618K in Q2 2019.
  • 47 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2020.

Based on Acadian Asset Management's 13F filing for Q3 2020, filed 9 Nov 2020.